69 Health Tech Startups in UK to Watch in 2024
How do we build this list?
Tracking:
Last update to the database: April 9, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
AI platform to map the human immune system. |
$14M · Series A | Life Extension Ventures, Molten Ventures | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@imubiosciences.com | ||
Developer of non-biological affinity reagents to accelerate the production of cell and gene therapies. |
$8M · Series A | Mercia Asset Management | 11 to 50 | Health Tech, Biotech | London, UK | •••••••••••@mipdiscovery.com | ||
Biomedical research discovery tool. |
$60M · Series B | ICONIQ Growth, Index Ventures, Pentech Ventures | 51 to 100 | Health Tech, AI, Biotech, Pharma | B2B, SaaS | London, UK | •••••••••••@causaly.com | |
Skin care telehealth platform. |
$52M · Series B | Village Global, Index Ventures, Headline | 101 to 250 | Health Tech | B2C | London, UK | •••••••••••@getharley.com | |
Oophthalmic gene therapy company to treat blinding retinal illnesses. |
$120M · Series A | Syncona Partners LLP | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@beacontx.com | ||
Virtual reality healthcare training platform. |
$12M · Series A | Frog Capital, ACF Investors, QVentures | 1 to 10 | Health Tech, Edtech | B2B, SaaS | London, UK | •••••••••••@oxfordmedicalsimulation.com | |
Cera Care is a London-based technology-enabled home care company. |
$64M | Oltre Venture | 5001 to 10000 | Health Tech, Mobile, Service Industry, ElderTech | B2B, B2C | London, UK | •••••••••••@ceracare.co.uk | |
Generative AI platform for doctors. |
$4M · Seed | Khosla Ventures, Entrepreneur First | 1 to 10 | Health Tech, AI | B2B, SaaS | London, UK | •••••••••••@tortus.ai | |
Workflow automation platform for the life sciences industry. |
$40M · Series B | Local Globe, Dimension, Hummingbird Ventures | 51 to 100 | Health Tech, Machine Learning | B2B | London, UK | •••••••••••@automata.tech | |
Clinical trials platform. |
$18M · Series A | Valar Ventures, Seedcamp, Atomico | 11 to 50 | Health Tech, Biotech | B2B, SaaS | London, UK | •••••••••••@lindushealth.com | |
At-home blood testing platform for cancer patients. |
$17M · Series A | Business Growth Fund, Parkwalk Advisors | 11 to 50 | Health Tech | B2B | London, UK | •••••••••••@entia.co | |
LabGenius is a biopharmaceutical company developing protein therapeutics using a machine learning-driven evolution engine. |
$25M | Kindred Capital, Atomico | 51 to 100 | Health Tech, AI, Biotech, Deep Tech, Machine Learning, Robotics, Manufacturing | B2B | London, UK | •••••••••••@labgeni.us | |
We’re going where no-one has ever gone before. -- We’re fighting cancer. -- Lives are at stake. |
$22M · Series A | Hoxton Ventures, Atomico, Connect Ventures | 11 to 50 | Health Tech, AI | B2B | London, UK | •••••••••••@kheironmed.com | |
User-owned genomics database platform. |
$20M · Series A | GEM Digital | 1 to 10 | Health Tech, Biotech | B2C | London, UK | •••••••••••@genomes.io | |
Fertility treatment for employees. |
$6M · Seed | Notion Capital, Passion Capital, Tiny VC | 1 to 10 | Health Tech | B2B | London, UK | •••••••••••@fertifa.com | |
Digital mental health platform for employees. |
$2M · Series A | IW Capital | 51 to 100 | Health Tech | B2B, SaaS | London, UK | •••••••••••@plummhealth.com | |
Huma provides a digital health platform used for predictive care and research. |
$25M · Series B | Unilever Ventures, Samsung NEXT | 101 to 250 | Health Tech, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@huma.com | |
Quell Therapeutics is a cell therapy company |
$45M · Series A | AlbionVC, Point72 Ventures | 101 to 250 | Health Tech, Edtech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@quell-tx.com | |
Diagnostic imaging platform. |
$12M · Series A | Triple Point Ventures | 51 to 100 | Health Tech | London, UK | •••••••••••@scan.com | ||
AI-driven financial management platform for hospitals. |
$3M · Seed | General Catalyst, Bertelsmann Investments, KHP Ventures | 1 to 10 | Health Tech, Fintech | B2B, SaaS | London, UK | •••••••••••@phare.health | |
Soft modular prosthetics maker for below-elbow limb. |
$1M · Seed | British Design Fund | 1 to 10 | Health Tech, Manufacturing | B2C | London, UK | •••••••••••@yourkoalaa.com | |
Platform to automate the clinical studies process. |
$12M · Series A | Playfair, Delin Ventures, 11.2 Capital | 11 to 50 | Health Tech, Biotech | B2B | London, UK | •••••••••••@umed.io | |
Gene silencing platform for the creation of programmable, allogeneic cell therapies. |
$16M · Seed | Mercia Asset Management, Calculus Capital, UK Innovation & Science Seed Fund | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@laverocktx.com | ||
Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. |
$30M · Series A | Kindred Capital, Octopus Ventures, Amadeus Capital | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@oribiotech.com | |
Cancer treatment predictor software. |
$14M · Series A | Hoxton Ventures, Octopus Ventures, Fly Ventures | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@pearbio.com | |
CHARM Therapeutics uses deep learning on 3D molecular configurations to develop molecule therapeutics to target pathogenic proteins. |
$50M · Series A | Khosla Ventures, General Catalyst | 1 to 10 | Health Tech, AI, Biotech, Data and Analytics | B2B | London, UK | •••••••••••@charmtx.com | |
Precision software for eye surgery. |
$8M · Seed | Redalpine | 1 to 10 | Health Tech, Biotech | London, UK | •••••••••••@hypervisionsurgical.com | ||
Oviva digitizes the treatment of type 2 diabetes and obesity through a unique behavior change platform. |
$21M · Series B | AlbionVC, Earlybird Venture Capital, Partech Ventures | 251 to 500 | Health Tech, Foodtech, CPG & Consumer Goods, Ecommerce | B2B | London, UK | •••••••••••@oviva.com | |
ReViral is a biotechnology company that develops and offers antiviral therapies for patients. |
$44M · Series C | Novo A/S, Andera Partners | 11 to 50 | Health Tech, Biotech, Pharma | B2B | London, UK | •••••••••••@reviral.co.uk | |
Intracellular screening platform. |
$51M · Series A | Columbus Venture Partners, British Patient Capital, Pfizer Venture Investments | 11 to 50 | Health Tech | Southampton, UK | •••••••••••@curvetx.com | ||
Perfect Ward is the health and quality inspection solution. |
$5M · Series A | octopus investments | 11 to 50 | Health Tech, Deep Tech, Robotics, Manufacturing | B2B, SaaS | London, UK | •••••••••••@perfectward.com | |
Numan is a startup which aims to tackle your tackle problem erectile dysfunction. |
$12M · Series A | Anthemis, VNV Global | 11 to 50 | Health Tech, Edtech | B2C | London, UK | •••••••••••@numan.com | |
UMotif is a scalable and engaging patient-centred data capture platform for modern research. |
$6M · Series A | AlbionVC | 51 to 100 | Health Tech, Data and Analytics, Creative Tools | B2B, SaaS | London, UK | •••••••••••@umotif.com | |
Myricx Pharma is a drug discovery company focused on developing small molecule inhibitors. |
$6M · Seed | Sofinnova Partners | 1 to 10 | Health Tech, Biotech, Deep Tech, Pharma | B2B | London, UK | •••••••••••@myricxpharma.com | |
Caeli Nova provides a technology system intended for the medicine and aviation sectors. |
$8M · Series A | LG Capital | 11 to 50 | Health Tech, Space Tech, Mobility & Transportation, Manufacturing | B2B | London, UK | •••••••••••@caelinova.com | |
Rensair is an electrical company that specializes in the fields of healthtech and electrical distribustion. |
$7M · Series A | Hoxton Ventures | 11 to 50 | Health Tech, Hardware, Manufacturing | B2B | London, UK | •••••••••••@rensair.com | |
AI-Powered healthcare platform. |
$5M · Seed | Hoxton Ventures, eHealth Ventures, JamJar Investments | 1001 to 5000 | Health Tech, AI | B2B, B2C | London, UK | •••••••••••@babylonhealth.com | |
Daye is a gynecological health company that creates products and services for vaginal treatment. |
$5M · Seed | Index Ventures, Khosla Ventures, Kindred Capital | 11 to 50 | Health Tech, Biotech, Manufacturing, Ecommerce, Cannabis | B2C | London, UK | •••••••••••@yourdaye.com | |
Lyphe group is a reliable supplier of medical cannabis care and medicine. |
$6M · Series A | Leafy Tunnel | 51 to 100 | Health Tech, Agritech, Pharma, Manufacturing, Cannabis | B2B | London, UK | •••••••••••@LYPHEGROUP.com | |
Review platform for healthcare. |
$10M · Series A | Beringea, Keen Venture Partners, Amadeus Capital | 51 to 100 | Health Tech, Identity Management | B2B, B2C, Marketplace | London, UK | •••••••••••@doctify.com | |
Clear aligner orthodontics. |
$2M · Seed | Balderton Capital | 11 to 50 | Health Tech | B2C | London, UK | •••••••••••@32co.com | |
eConsult Health is the leading digital triage provider to the NHS. |
$9M · Series A | Calculus Capital, Gresham House Ventures | 101 to 250 | Health Tech, Edtech | B2B, Marketplace | London, UK | •••••••••••@econsult.net | |
FitXR is on a mission to create a movement for movement |
$7M | Hiro Capital | 51 to 100 | Health Tech, Gaming, AR / VR, Sportstech, Fitness | B2C, SaaS | London, UK | •••••••••••@fitxr.com | |
Manual provides diagnostic tools and testing to help patients make health-related decisions. |
$6M · Seed | Felix Capital, Cherry Ventures, FJ Labs | 11 to 50 | Health Tech, Fashion, Pharma, Mobile, Ecommerce | B2C | London, UK | •••••••••••@manual.co | |
Cancel support platform. |
$4M · Seed | Octopus Ventures | 1 to 10 | Health Tech | London, UK | •••••••••••@percihealth.com | ||
Skin Analytics uses artificial intelligence to screen for melanoma skin cancer. |
$5M · Series A | Hoxton Ventures | 11 to 50 | Health Tech, AI, Data and Analytics, Business Intelligence | B2B, SaaS | London, UK | •••••••••••@skin-analytics.com | |
Patient management platform. |
$12M · Series B | YFM Equity Partners | 11 to 50 | Health Tech | London, UK | •••••••••••@drdoctor.co.uk | ||
Pathfinder is developing a novel catheter based system that provides a better way for patients to receive haemodialysis for kidney failure. |
$11M · Series A | Business Growth Fund, Deepbridge Capital, Parkwalk Advisors | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | London, UK | •••••••••••@pathfindermed.com | |
Fitness game developers. |
$9M · Series A | Khosla Ventures, Heartcore, Tencent | 11 to 50 | Health Tech, Gaming, Sportstech, Fitness, Manufacturing | B2C | London, UK | •••••••••••@playquell.com | |
Therapy and coaching platform. |
$20M · Series B | Octopus Ventures, Omers Ventures | 51 to 100 | Health Tech, Fitness | B2B, B2C, Marketplace | London, UK | •••••••••••@helloself.com | |
Flo is an AI-powered women’s health app that supports women at every stage of their reproductive cycle. |
$7M · Series A | Target Global, VNV Global | 251 to 500 | Health Tech, Mobile, Business Intelligence | B2C, Freemium | London, UK | •••••••••••@flo.health | |
At-home fertility treatment. |
$3M · Seed | Octopus Ventures, Calm/Storm Ventures, QVentures | 1 to 10 | Health Tech, Biotech | B2C | London, UK | •••••••••••@beafertility.com | |
AI-driven mental health assessment platform. |
$2M · Seed | Entrepreneur First, Kodori AG, Form Ventures | 1 to 10 | Health Tech, AI | SaaS | London, UK | •••••••••••@thymia.ai | |
Accurx is on a mission to make patients healthier and healthcare staff happier, through seamless communication. |
$11M · Series A | Local Globe, Atomico, Latitude | 101 to 250 | Health Tech | B2B, SaaS | London, UK | •••••••••••@accurx.com | |
Hertility Health is on a mission to revolutionise the world of reproductive health. |
$5M · Seed | Local Globe | 11 to 50 | Health Tech | B2B, B2C | London, UK | •••••••••••@hertilityhealth.com | |
AR therapy for Parkinson's disease. |
$2M · Seed | SFC Capital, Kluz Ventures, Midlands Engine Investment Fund | 11 to 50 | Health Tech, AR / VR | B2C | London, UK | •••••••••••@strolll.co | |
Digital hospital of the future, providing elective medical procedures with a fully-digitised, personal and patient-first experience. |
$7M · Series A | Talis Capital, Cavalry Ventures Management, Signals Venture Capital | 11 to 50 | Health Tech | B2C, Marketplace | London, UK | •••••••••••@medbelle.com | |
Quantum simulation platform for drug discovery. |
$2M · Seed | Ascension Ventures, ACF Investors | 1 to 10 | Health Tech, Biotech | B2B, SaaS | London, UK | •••••••••••@kuano.ai | |
Digital healthcare program for people with ADHD. |
$11M · Series A | Hoxton Ventures, Octopus Ventures, Y Combinator | 11 to 50 | Health Tech, Mobile | B2C | London, UK | •••••••••••@getinflow.io | |
Thriva offers a personalized at-home finger-prick blood test which enables individuals to easily track and improve health. |
$7M · Series A | Target Global, Pembroke VCT | 101 to 250 | Health Tech, Consumer Social, Media and Entertainement, Ecommerce | B2C | London, UK | •••••••••••@thriva.co | |
Palta is a health and wellbeing technology company |
$14M · Series A | Target Global, VNV Global | 501 to 1000 | Health Tech, Mobile | B2B, B2C | London, UK | •••••••••••@palta.com | |
Florence is an online marketplace that connects vacant care home shifts to local nurses and carers looking for extra work |
$6M · Series A | AXA Venture Partners | 51 to 100 | Health Tech, Hiring and Recruitement, ElderTech | B2B, B2C, Marketplace | London, UK | •••••••••••@florence.co.uk | |
Immunotherapies intended to offer next-generation, patient-specific therapies to treat cancer. |
$17M · Seed | AlbionVC, Boxer Capital, Syncona Partners LLP | 101 to 250 | Health Tech, Biotech | B2B | London, UK | •••••••••••@achillestx.com | |
Jude is a healthcare company dedicated to breaking bladder taboos, promoting incontinence awareness. |
$4M · Seed | Eka Ventures, Joyance Partners, Samos Investments | 11 to 50 | Health Tech, Manufacturing, Ecommerce | B2C | London, UK | •••••••••••@wearejude.com | |
Fresha provides an online platform for booking beauty and wellness appointments with local businesses. |
$20M · Series B | Partech Ventures, Target Global, FJ Labs | 251 to 500 | Health Tech, Fashion, Ecommerce | B2B, B2C, SaaS | London, UK | •••••••••••@fresha.com | |
Sixfold Bioscience develops and researches on biotechnology advances for RNA therapies. |
$10M | Y Combinator, Pi Campus | 11 to 50 | Health Tech, Biotech, Robotics, Manufacturing, Business Intelligence | B2B | London, UK | •••••••••••@sixfold.bio | |
Yoppie is a menstrual wellness brand, that helps women get access to quality products, align with their menstrual cycle. |
$3M · Seed | VNV Global | 11 to 50 | Health Tech, Mobile, Manufacturing, Community & Lifestyle, Ecommerce | B2C, SaaS | London, UK | •••••••••••@yoppie.com | |
Peanut is an online platform that provides a safe space for women to connect across fertility and motherhood. |
$5M · Series A | Felix Capital, Index Ventures, EQT Ventures | 11 to 50 | Health Tech, Messaging, Mobile, Consumer Social, Community & Lifestyle, FamilyTech & Parenting | Freemium | London, UK | •••••••••••@peanut-app.io | |
We are a translational biophysics company focusing on the discovery of novel therapeutics against intrinsically disordered proteins. |
$2M | Hoxton Ventures, Bessemer Venture Partners | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | London, UK | •••••••••••@peptone.io |
Sign up to access our full database
Enter your email and get access to 17,000+ technology companies you can partner with.